ACXP - Acurx Pharmaceuticals GAAP EPS of -$0.25 May, 12 2023 07:02 AM Acurx Pharmaceuticals Inc. 2023-05-12 07:02:59 ET Acurx Pharmaceuticals press release ( NASDAQ: ACXP ): Q1 GAAP EPS of -$0.25. The Company ended the quarter, with cash totaling $7.2 million compared to $9.1 million as of December 31, 2022. For further details see: Acurx Pharmaceuticals GAAP EPS of -$0.25